Patents by Inventor David Roger Borcherding

David Roger Borcherding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7541368
    Abstract: The present invention provides compounds of Formula (I) and ester prodrugs, pharmaceutically acceptable salts or solvates of such compounds; or ester prodrugs of such salts or solvates; pharmaceutical compositions comprising such compounds, their preparation, and their pharmaceutical use in the treatment of disease states capable of being modulated by the inhibition of p38 kinase and/or tumor necrosis factor (TNF).
    Type: Grant
    Filed: November 1, 2005
    Date of Patent: June 2, 2009
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: David Roger Borcherding, Alexandre Gross, Patrick W. Shum, Nicole Willard, Brian S. Freed